DexCom revenue and financials

DXCM · NASDAQ · USD

$86.90+1.80%+$1.54

Close · October 5, 2026

In the fiscal year ended December 2025, DexCom reported revenue of $4.66B (+15.60% year over year). Net income was $836.3M, a net margin of 17.9%.

Annual revenue · 2025: $4.66B

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	6,340	6,485	6,265	5,392	4,864	4,291	2,395	1,916	904	403
Current assets	4,033	4,301	4,426	3,669	3,684	3,425	1,969	1,700	745	280
Cash and equivalents	918	606	566	642	1,053	818	446	1,137	442	94.5
Short-term investments	1,081	1,973	2,158	1,814	—	—	—	—	—	—
Receivables	1,290	1,044	988	752	—	—	—	—	—	—
Inventory	629	543	560	307	—	—	—	—	—	—
Net property, plant and equipment	1,637	1,403	1,185	1,136	—	—	—	—	—	—
Goodwill	24.2	22.8	25.2	25.7	26.5	19.3	18.6	18.7	12.1	11.3
Other intangible assets	70.8	103	135	173	—	—	—	—	—	—
Long-term investments	218	119	38.5	19.0	—	—	—	—	—	—
Current liabilities	2,143	2,932	1,556	1,839	721	614	360	222	139	102
Accounts payable	344	345	276	238	—	—	—	—	—	—
Long-term debt	1,241	1,237	2,434	1,198	—	—	—	—	—	—
Total debt	1,390	2,587	2,594	2,145	—	—	—	—	—	—
Total liabilities	3,594	4,382	4,196	3,260	2,612	2,464	1,512	1,253	485	119
Total equity (incl. minority)	2,746	2,103	2,069	2,132	—	—	—	—	—	—
Retained earnings	2,434	1,598	1,021	480	—	—	—	—	—	—